Document:

exv10w1

Exhibit 10.1

CONSULTING AGREEMENT

     THIS CONSULTING AGREEMENT (the “Agreement”), made this 1st day of April, 2010 (“Effective
Date”) is entered into by Idera Pharmaceuticals, Inc., a Delaware corporation with its principal
place of business at 167 Sidney Street, Cambridge, MA 02139 (the “Company”), and Malcolm MacCoss,
Ph.D., an individual being a Member of Bohicket Pharma Consulting LLC and having a place of
residence located 2556 Seabrook Island Road, Seabrook Island, SC 29455 (the “Consultant”). Company
and Consultant may be referred to herein individually as a “Party” and collectively as the
“Parties.”

INTRODUCTION

     The Company desires to retain the services of the Consultant and the Consultant desires to
perform certain Services, as defined below, for the Company. In consideration of the mutual
covenants and promises contained herein and other good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged by the Parties, the Parties agree as follows:

     1. Services. The Consultant agrees to perform such consulting, advisory and related
services to and for the Company as may be reasonably requested from time to time by the Company
(“Service”). Such Services shall be performed at such location, on such days, and at such times as
may be reasonably agreed by the Company and the Consultant. Such Services, if any, shall be
performed on an as needed basis.

     2. Term. This Agreement shall commence on the Effective Date and shall continue until
December 31, 2010 (such period, as it may be extended, being referred to as the “Consultation
Period”), unless sooner terminated in accordance with the provisions of Section 4.

     3. Compensation.

          3.1 Consulting Fees. The Consultant shall be entitled to $375 per hour, not to exceed
$3,000 per day, of Service actually performed by the Consultant hereunder. The Consultant shall
submit to the Company monthly statements, in a form substantially the same as that shown in Exhibit
A, detailing Services performed for the Company in the previous month. The Company shall pay to
the Consultant consulting fees with respect to all Services actually performed and invoiced within
30 days after Company’s receipt of each monthly invoice.

          3.2 Reimbursement of Expenses. The Company shall reimburse the Consultant for all
reasonable and necessary expenses incurred or paid by the Consultant in connection with, or related
to, the performance of his Services under this Agreement and in accordance with Idera Policy No.
217, which is attached as exhibit B. The Consultant shall submit to the Company itemized monthly
statements, in a form satisfactory to the Company, of such expenses incurred in the previous month.
The Company shall pay to the Consultant amounts shown on each such statement within 30 days after
Company’s receipt thereof.
Notwithstanding the foregoing, the Consultant shall not incur total expenses in excess of
$1,000 per month without the prior written approval of the Company.

1

 

          3.3 Benefits. The Consultant shall not be entitled to any benefits, coverages or
privileges made available to employees of the Company, including, without limitation, social
security, unemployment, medical or pension payments.

     4. Termination. Each of the Company and the Consultant may terminate the Consultation
Period upon 30 days’ prior written notice to the other Party. In the event of such termination,
the Consultant shall be entitled to payment for Services performed and expenses paid or incurred
prior to the effective date of termination, subject to the limitation on reimbursement of expenses
set forth in Section 3.2. Notwithstanding the foregoing, the Company may terminate the
Consultation Period, effective immediately upon receipt of written notice, if the Consultant
breaches or threatens to breach any provision of Section 6 of this Agreement.

     5. Cooperation. The Consultant shall use his best efforts in the performance of his
obligations under this Agreement. The Company shall provide such access to its information and
property as may be reasonably required in order to permit the Consultant to perform his obligations
hereunder. The Consultant shall cooperate with the Company’s personnel, shall not interfere with
the conduct of the Company’s business and shall observe all rules, regulations, and security
requirements of the Company concerning the safety of persons and property.

     6. Inventions and Proprietary Information.

          6.1 Inventions.

               (a) All inventions, discoveries, computer programs, data, technology, designs, innovations and
improvements (whether or not patentable and whether or not copyrightable) (“Inventions”) which are
made, conceived, reduced to practice, created, written, designed or developed by the Consultant,
solely or jointly with others and whether during normal business hours or otherwise, (i) during the
Consultation Period if related to the business of the Company or (ii) after the Consultation Period
if resulting or directly derived from Proprietary Information (as defined below), shall be the sole
property of the Company. The Consultant hereby assigns to the Company all Inventions and any and
all related patents, copyrights, trademarks, trade names, and other industrial and intellectual
property rights and applications therefor, in the United States and elsewhere and appoints any
officer of the Company as his duly authorized attorney to execute, file, prosecute and protect the
same before any government agency, court or authority. Upon the request of the Company and at the
Company’s expense, the Consultant shall execute such further assignments, documents and other
instruments as may be necessary or desirable to fully and completely assign all Inventions to the
Company and to assist the Company in applying for, obtaining and enforcing patents or copyrights or
other rights in the United States and in any foreign country with respect to any Invention. The
Consultant also hereby waives all claims to moral rights in any Inventions.

               (b) The Consultant shall promptly disclose to the Company all Inventions and will maintain
adequate and current written records (in the form of notes, sketches,
drawings and as may be specified by the Company) to document the conception and/or first
actual reduction to practice of any Invention. Such written records shall be available to and
remain the sole property of the Company at all times.

2

 

          6.2 Proprietary Information.

               (a) The Consultant acknowledges that his relationship with the Company is one of high trust
and confidence and that in the course of his service to the Company he will have access to and
contact with confidential information. The Consultant agrees that during the Consultation Period,
any information conveyed to him will be subject to the Confidential Disclosure Agreement between
Idera and Consultant, dated 8 February 2010.

               (b) The Consultant represents that his retention as a consultant with the Company and his
performance under this Agreement does not, and shall not, breach any agreement that obligates him
to keep in confidence any trade secrets or confidential or proprietary information of his or of any
other party or to refrain from competing, directly or indirectly, with the business of any other
party. The Consultant shall not disclose to the Company any trade secrets or confidential or
proprietary information of any other party.

               (c) The Consultant acknowledges that the Company from time to time may have agreements with
other persons or with the United States Government, or agencies thereof, that impose obligations or
restrictions on the Company regarding inventions made during the course of work under such
agreements or regarding the confidential nature of such work. The Consultant agrees to be bound by
all such obligations and restrictions that are known to him and to take all action necessary to
discharge the obligations of the Company under such agreements.

          6.3 Remedies. The Consultant acknowledges that any breach of the provisions of this
Section 6 may cause immediate, substantial, and irreparable harm to Company, for which monetary
damages may not be a sufficient remedy. In the event of a breach of this Agreement, in addition to
any other remedy it may have, the Company shall be entitled to seek specific performance of this
Agreement by the Consultant and to seek injunctive relief in any court of competent
jurisdiction.

     7. Independent Contractor Status. The Consultant shall perform all Services
under this Agreement as an “independent contractor” and not as an employee or agent of the Company.
The Consultant is not authorized to assume or create any obligation or responsibility, express or
implied, on behalf of, or in the name of, the Company or to bind the Company in any manner.

     8. Notices. All notices required or permitted under this Agreement shall be in
writing and shall be deemed effective upon personal delivery or upon deposit in the United States
Post Office, by registered or certified mail, postage prepaid, addressed to the other Party at the
address shown above, or at such other address or addresses as either Party shall designate to the
other in accordance with this Section 8.

     9. Pronouns. Whenever the context may require, any pronouns used in this Agreement
shall include the corresponding masculine, feminine or neuter forms, and the singular forms of
nouns and pronouns shall include the plural, and vice versa.

     10. Entire Agreement. This Agreement constitutes the entire agreement between the
Parties and supersedes all prior agreements and understandings, whether written or oral, relating
to the subject matter of this Agreement.

3

 

     11. Amendment. This Agreement may be amended or modified only by a written instrument
executed by both the Company and the Consultant.

     12. Governing Law. This Agreement shall be construed, interpreted and enforced in
accordance with the laws of the Commonwealth of Massachusetts.

     13. Successors and Assigns. This Agreement shall be binding upon, and inure to the
benefit of, both Parties and their respective successors and assigns, including any corporation
with which, or into which, the Company may be merged or which may succeed to its assets or
business, provided, however, that the obligations of the Consultant are personal and shall not be
assigned by him.

     14. Miscellaneous.

          14.1 No delay or omission by the Company in exercising any right under this Agreement shall
operate as a waiver of that or any other right. A waiver or consent given by the Company on any
one occasion shall be effective only in that instance and shall not be construed as a bar or waiver
of any right on any other occasion.

          14.2 The captions of the sections of this Agreement are for convenience of reference only and
in no way define, limit or affect the scope or substance of any section of this Agreement.

          14.3 In the event that any provision of this Agreement shall be invalid, illegal or otherwise
unenforceable, the validity, legality and enforceability of the remaining provisions shall in no
way be affected or impaired thereby.

     IN WITNESS WHEREOF, the Parties have executed this Agreement as of the Effective Date.

	 	 	 	 	 	 	 	 	 	 	 

	IDERA PHARMACEUTICALS, INC.	 	 	 	MALCOLM MACCOSS	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By:  /s/ Louis Arcudi, III
	 	 	 	By:  /s/ Malcolm MacCoss
	 	 
	Louis Arcudi, III

	 	 	 	Malcolm MacCoss, Ph.D., FRSC
	 	 
	Chief Financial Officer
	 	 	 	 	 	 	 	 
	Date:

	 	April 7, 2010	 	 	 	Date:
	 	April 1, 2010	 	 
	 

	 	 	 	 	 	 
	 	 	 	 

4

 

Exhibit A

Sample Invoice/Report

Malcolm MacCoss, Ph.D.

Date:                                         

Attn: Accounts Payable

Idera Pharmaceuticals, Inc.

167 Sidney Street

Cambridge, MA 02139

Fax: 617-679-5560

Dear                                         ,

In accordance with my Consulting Services Agreement with Idera, dated                      March 2010, the following
summarizes services performed for the invoice period of                                          to                              
           :

	 	 	 	 	 	 	 	 	 
	 
	 	Date(s):

	 	 	Description of Activity:
	 	 	Time:	 
	 	 

	 	 	 	 	 	___hr(s).	 
	 	 

	 	 	 	 	 	___hr(s).	 
	 

In accordance with the Consulting Services Agreement, please remit the payment of                                          within
30 days.

Regards,

Malcolm MacCoss, Ph.D.

 

Idera Approval

	 	 	 	 	 	 	 	 	 	 	 

	Idera Manager: 

	 	 	 	 	 	Date:	 	 	 	 
	
	 	 	 	 	 	 

	 	 
	Total Amount Approved: $

	 	 	 	 	 	 	 	 

5

 

Exhibit B

Idera Pharmaceuticals, Inc. Travel Policy (POLICY NO. 217)

TRAVEL & ENTERTAINMENT

	 	 	 
	PURPOSE:
	 	To establish guidelines for Company travel and entertainment and
to ensure travel is consistent with Idera’s business objectives.

	 	 	 

	SCOPE:
	 	All Idera employees, directors, and consultants (“Employees”).

	 	 	 

	POLICY:
	 	Idera will reimburse Employees who travel on approved Company
business for all necessary reasonable business expenses.
However, in no event will reimbursement exceed actual expenses.
Neither luxury, nor sub-standard modes of transportation and
accommodations should be used.

PROCEDURE FOR TRAVEL:

Employees are expected to pay for their travel with personal credit cards or cash. Employees are
expected to pay their own credit card bill and any late fees or finance charges are the
responsibility of the Employee. Any credit card rewards from use of the card belong to the
Employee.

PROCEDURE FOR REIMBURSEMENT:

	 	1.	 	Upon return from your pre-approved business related travel, Idera requires the Employee
to submit an original travel and expense report with the business purpose identified.
Travel should be via the lowest cost alternative within reason. All original
receipts are requested but receipts for expenses greater than $20 are required. Expense
reports must be submitted in a timely fashion. Please attach original receipts to your
travel and expense report and complete within 5 business days from your return. Deduct any
personal expenses. Any receipts not provided must be noted on the travel and expense
report. If business travel was overseas, convert to U.S. dollars and list the exchange
rate used.
	 
	 	2.	 	Travel and expense reports must be signed by the Employee and approved by the
Employee’s manager before forwarding to accounting. Reimbursement will be made via the
next scheduled check run, which should be within 15 days after the accounting department
receives an approved travel and expense report.
	 
	 	3.	 	In the event that the Employee owes the Company funds, the funds should accompany the
completed travel and expense report. Any amounts due the Company and not paid will be
deducted from any future payment requests.
	 
	 	4.	 	Any expense submitted that does not comply with the guidelines of this policy will not
be reimbursed, unless accompanied by a valid exception approved by the CFO, President or
CEO.

LODGING:

6

 

Employees are permitted to reserve hotel rooms for out of town travel. Neither luxury, nor
sub-standard accommodations should be used. Employees will only be reimbursed for standard hotel
rooms. No upgrades to suites are permitted. Saturday night stays are permitted, but not required,
if the stay results in airfare savings in excess of the extra night(s) stay and meals. Where
appropriate, Employees are expected to book their accommodations using conference hotels and
discounts. It is the Employee’s responsibility to cancel reservations not expected to be utilized.
The Company will not reimburse no show fees.

AIRFARE:

Air travel will be via the most direct and economical means. Employees are expected to
book their airfare as far in advance as possible — at least seven days in most instances. Use of
“Non-Refundable” airfare is recommended. (In most cases, if the travel must change or the trip is
canceled all together, the funds can be used as a credit toward future travel, less a service
charge imposed by the airline. Employees must include this credit on their next travel and expense
report that includes air travel.) Employees may fly business class on international flights where
in-flight time exceeds six hours in duration. Benefits from frequent flier memberships are
considered to belong to the Employee. The Company does not reimburse any fees or dues associated
with such memberships.

PERSONAL TRANSPORTATION/MILEAGE:

Employees with a valid driver’s license may submit expenses for the use of their personal car while
on business. Employees will be reimbursed the standard IRS rate for every mile driven on behalf of
the Company that exceeds their normal commuting mileage, defined as from the Employee home to the
Company’s facility. Receipts should be submitted for any parking expenses or tolls.

RENTAL CARS:

Compact or mid size cars can be rented when having a car is deemed necessary (ie. taxi cabs are not
prevalent or the distance from the airport or hotel to the destination is excessive). When
possible, every effort should be made to return rental cars with the proper fuel level. Receipts
should be submitted for gas with the T&E report. Additional liability and physical damage insurance
should be waived for cars rented in the United States as the Company’s travel insurance policy
covers Company travel via rental cars. Employees renting cars should include the Company’s name
somewhere on the rental agreement. Additional liability and physical damage insurance should be
purchased from the rental agency for cars rented outside the United States.

TRAIN FARE:

Train travel will be via the most direct and economical means. Employees are expected
to book their train fare as far in advance as possible. Use of “Non-Refundable” train fare is
recommended. The Acela express service, where all seats are business class, is permitted for

7

 

travel between Boston and New York and DC. Employees may use first class train accommodations where
on-train time exceeds seven hours in duration. Benefits from frequent traveler memberships are
considered to belong to the Employee. The Company does not reimburse any fees or dues associated
with such memberships.

TELEPHONE/FACSIMILES/INTERNET SERVICES:

Reasonable expenses incurred while traveling for telephone, fax, internet, and telegraph for
Company business communications are reimbursable. Where applicable, Employees should use their
Company issued cell phones when traveling and not incur extensive calls through their hotel rooms.
Necessary business calls made from the Employee’s residence are reimbursable. A copy of the
telephone bill and an explanation of the business purpose should be submitted with your travel and
expense report.

BUSINESS MEALS AND ENTERTAINMENT:

Meals. Individual meals can be purchased while an Employee is traveling for approved business
purposes. Individual meals will be reimbursed at the lower of $30 per meal or $50 per day.

When in the best interest of the Company, meals may be purchased for clients, affiliates, and
others with whom the Company has business dealings. In addition, the government requires detailed
record keeping legitimizing the expense. The items to be documented are:

	 	•	 	Individuals present
	 
	 	•	 	Business affiliations
	 
	 	•	 	Location
	 
	 	•	 	Date
	 
	 	•	 	BUSINESS PURPOSE OF MEETING. This can be a short phrase such as “discuss new business”,
“conduct employee review”, or “scientific discussions”

Reimbursements may include gratuities up to a maximum of 20%.

Entertainment — Entertainment expenses are generally not reimbursed by the Company. Entertainment
expenses are only reimbursable with management prior approval. Pre-approved entertainment will
only be reimbursed where an original receipt is submitted with the T & E report.

NON-REIMBURSABLE EXPENSES, include but are not limited to the following:

	 	•	 	Airline club or other travel memberships
	 
	 	•	 	Airline upgrade coupon booklets
	 
	 	•	 	Airline headsets
	 
	 	•	 	Sundries
	 
	 	•	 	Laundry services (unless a trip is unexpectedly extended)
	 
	 	•	 	Lost airline tickets applications
	 
	 	•	 	Mini-bar services
	 
	 	•	 	In room movies

8

 

	 	•	 	Barber/Hair Stylist
	 
	 	•	 	Manicurist
	 
	 	•	 	Masseur/Spa services
	 
	 	•	 	Birthday or other celebration gifts
	 
	 	•	 	Unauthorized donations, contributions
	 
	 	•	 	Car insurance
	 
	 	•	 	Personal items other than emergency services items purchased while traveling because of
lost or damaged baggage
	 
	 	•	 	Clothing purchases
	 
	 	•	 	Personal liquor or entertainment when not included in a business dinner
	 
	 	•	 	Traffic violations and citations
	 
	 	•	 	Pet care, lawn care and snow removal while traveling
	 
	 	•	 	Theft, loss or damage to personal property
	 
	 	•	 	Cash advances and ATM fees
	 
	 	•	 	Daily newspapers while traveling

9exv10w2

Exhibit 10.2

AMENDMENT NO. 2 TO THE CONSULTING SERVICES AGREEMENT

This Amendment No. 2, effective the 15th day of December, 2009, (“Amendment No. 2 Date”)
is by and between Idera Pharmaceuticals, Inc., a Delaware corporation, having a place of
business at 167 Sidney Street, Cambridge, Massachusetts 02139 (hereinafter referred to as “Idera”)
and Karr Pharma Consulting, LLC, having a place of business at 707 Dominion Drive, St.
Louis, Missouri 63131 (hereinafter referred to as the “Consultant”). Idera and Consultant may be
referred to herein individually as a “Party” and collectively as the “Parties.”

Background

The Parties entered into a Consulting Services Agreement (“Agreement”), dated January 1, 2008
(“Effective Date”), which set forth certain terms and conditions for the Consultant to perform
services for Idera.

The Parties amended the Agreement on December 16, 2008, to extend the term through December 31,
2009.

The Parties now desire to amend the Agreement to further extend the term through December 31, 2010.

Now, Therefore, the Parties hereby agree as follows:

Section 2 of the Agreement shall be amended and restated in its entirety as follows:

TERM. This Agreement commences on the Effective Date and continues until December 31, 2010 (such
period, as it may be extended, being referred to as the “Consultation Period”), unless sooner
terminated in accordance with the provisions of Section 4.

All other terms and conditions of the Agreement, as amended on December 16, 2008, remain in full
force and effect.

IN WITNESS WHEREOF, the Parties have executed this Amendment No. 2 as of the Amendment No. 2 Date.

	 	 	 	 	 	 	 	 	 	 	 

	Idera Pharmaceuticals, Inc.	 	 	 	Karr Pharma Consulting, LLC	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By: /s/ Louis J. Arcudi, III
	 	 	 	By: /s/ Robert W. Karr  
	 	 
	Louis J. Arcudi, III
	 	 	 	Robert W. Karr, M.D.
	 	 
	Chief Financial Officer
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Date:

	 	12-18-09	 	 	 	Date:	 	12-15-09	 	 
	 

	 	 

	 	 	 	 	 	 

	 	 

Confidential

Page 1 of 4

 

CONSULTING AGREEMENT

     THIS CONSULTING AGREEMENT (the “Agreement”), made this 1st day of January, 2008
(“Effective Date”) is entered into by Idera Pharmaceuticals, Inc., a Delaware corporation with its
principal place of business at 167 Sidney Street, Cambridge, MA 02139
(the “Company”), and Karr
Pharma Consulting, LLC, having a place of business located at 30 Ox Bow Lane, Essex, Connecticut
06426 (the “Consultant”). Company and Consultant may be referred to herein individually as a
“Party” and collectively as the “Parties.”

INTRODUCTION

     The Company desires to retain the services of the Consultant and the Consultant desires to
perform certain Services, as defined below, for the Company. In consideration of the mutual
covenants and promises contained herein and other good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged by the Parties, the Parties agree as follows:

     1.      Services. The Consultant agrees to perform such consulting, advisory and related
services to and for the Company as may be reasonably requested from time to time by the Company
(“Service”). Such Services shall be performed at such location, on such days, and at such times as
may be reasonably agreed by the Company and the Consultant. Such Services, if any, shall be
performed on an as needed basis.

     2.      Term. This Agreement shall commence on the Effective Date and shall continue until
December 31, 2008 (such period, as it may be extended, being referred to as the “Consultation
Period”), unless sooner terminated in accordance with the provisions of Section 4.

     3.      Compensation.

               3.1    Consulting Fees. The Consultant shall be entitled to $375 per hour, not to exceed
$3,000 per day, of Service actually performed by the Consultant hereunder. The Consultant shall
submit to the Company monthly statements, in a form satisfactory to the Company, detailing Services
performed for the Company in the previous month. The Company shall pay to the Consultant
consulting fees with respect to all Services actually performed and invoiced within 30 days after
Company’s receipt of each monthly invoice.

               3.2    Reimbursement of Expenses. The Company shall reimburse the Consultant for all
reasonable and necessary expenses incurred or paid by the Consultant in connection with, or related
to, the performance of his Services under this Agreement. The Consultant shall submit to the
Company itemized monthly statements, in a form satisfactory to the Company, of such expenses
incurred in the previous month. The Company shall pay to the Consultant amounts shown on each such
statement within 30 days after Company’s receipt thereof. Notwithstanding the foregoing, the
Consultant shall not incur total expenses in excess of $ 1,000 per month without the prior
written approval of the Company.

               3.3    Benefits. The Consultant shall not be entitled to any benefits, coverages or
privileges made available to employees of the Company, including, without limitation, social
security, unemployment, medical or pension payments.

Page 2 of 4

 

     4.      Termination. Each of the Company and the Consultant may terminate the Consultation
Period upon 30 days’ prior written notice to the other Party. In the event of such termination,
the Consultant shall be entitled to payment for Services performed and expenses paid or incurred
prior to the effective date of termination, subject to the limitation on reimbursement of expenses
set forth in Section 3.2. Notwithstanding the foregoing, the Company may terminate the
Consultation Period, effective immediately upon receipt of written notice, if the Consultant
breaches or threatens to breach any provision of this Agreement or Section 7, 8 or 9 of the
Employment Agreement (as defined below).

     5.      Cooperation. The Consultant shall use his best efforts in the performance of his
obligations under this Agreement. The Company shall provide such access to its information and
property as may be reasonably required in order to permit the Consultant to perform his obligations
hereunder. The Consultant shall cooperate with the Company’s personnel, shall not interfere with
the conduct of the Company’s business and shall observe all rules, regulations and security
requirements of the Company concerning the safety of persons and property.

     6.      Employment Agreements.

                    (a)      The Company and the Consultant acknowledge and agree that this Consulting Agreement shall
take effect immediately following the effectiveness of the Consultant’s resignation as an officer
and employee of the Company and the termination of the Employment Period (as defined in the
Employment Agreement dated as of December 5, 2005 between the Company and the Consultant (the
“Employment Agreement”)).

                    (b)      The Consultant hereby agrees that during the Consulting Period he shall continue to be
bound by and subject to the provisions of Sections 7, 8 and 9 of the Employment Agreement, as if he
continued to be an employee of the Company during the Consultation Period and that references in
such Sections to the termination or cessation of employment shall be deemed to mean the termination
or cessation of the Consultation Period hereunder. For example, as a result of this Section 6(b),
the Consultant shall be subject to and bound by the non-competition and non-solicitation
obligations set forth in Section 8 of the Employment Agreement during the Consultation Period and
for a period of one year after the termination or cessation of the Consultation Period for any
reason.

     7.      Independent Contractor Status. The Consultant shall perform all Services under
this Agreement as an “independent contractor” and not as an employee or agent of the Company. The
Consultant is not authorized to assume or create any obligation or responsibility, express or
implied, on behalf of, or in the name of, the Company or to bind the Company in any manner.

     8.      Notices. All notices required or permitted under this Agreement shall be in
writing and shall be deemed effective upon personal delivery or upon deposit in the United States
Post Office, by registered or certified mail, postage prepaid, addressed to the other Party at the
address shown above, or at such other address or addresses as either Party shall designate to the
other in accordance with this Section 8.

Page 3 of 4

 

     9.      Pronouns. Whenever the context may require, any pronouns used in this Agreement
shall include the corresponding masculine, feminine or neuter forms, and the singular forms of
nouns and pronouns shall include the plural, and vice versa.

     10.     Entire Agreement. This Agreement constitutes the entire agreement between the
Parties and supersedes all prior agreements and understandings, whether written or oral, relating
to the subject matter of this Agreement.

     11.     Amendment. This Agreement may be amended or modified only by a written instrument
executed by both the Company and the Consultant.

     12.     Governing Law. This Agreement shall be construed, interpreted and enforced in
accordance with the laws of the Commonwealth of Massachusetts.

     13.     Successors and Assigns. This Agreement shall be binding upon, and inure to the
benefit of, both Parties and their respective successors and assigns, including any corporation
with which, or into which, the Company may be merged or which may succeed to its assets or
business, provided, however, that the obligations of the Consultant are personal and shall not be
assigned by him.

     14.     Miscellaneous.

               14.1    No delay or omission by the Company in exercising any right under this Agreement shall
operate as a waiver of that or any other right. A waiver or consent given by the Company on any
one occasion shall be effective only in that instance and shall not be construed as a bar or waiver
of any right on any other occasion.

               14.2    The captions of the sections of this Agreement are for convenience of reference only and
in no way define, limit or affect the scope or substance of any section of this Agreement.

               14.3    In the event that any provision of this Agreement shall be invalid, illegal or otherwise
unenforceable, the validity, legality and enforceability of the remaining provisions shall in no
way be affected or impaired thereby.

     IN WITNESS WHEREOF, the Parties have executed this Agreement as of the Effective Date.

	 	 	 	 	 	 	 	 	 
	IDERA PHARMACEUTICALS, INC.	 	 	 	KARR PHARMA CONSULTING,
LLC

	By:

	 	 /s/ Lou Arcudi	 	 
	 	By:
	 	 /s/ Robert W. Karr
	 

	 	 
	 	 
	 	 	 	 
	Lou Arcudi	 	 	 	Robert W. Karr, M.D.
	CFO
	 	 	 	 	 	 	 	 
	Date:

	 	 1-2-08	 	 	 	Date:
	 	 1-2-08
	 

	 	 
	 	 	 	 	 	 

Page 4 of 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00172-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00172-of-00352.parquet"}]]